CDK2 and cancer: CDK2 contributes to mediate cell cycle, and its aberrant activation has been implicated in the pathogenesis of various cancers, such as pulmonary 19, mammary gland 40, hepatic 41, and esophageal squamous epithelium 42 carcinogenesis.